Karine Guerrier1, David Kwiatkowski2, Richard J Czosek2, David S Spar2, Jeffrey B Anderson2, Timothy K Knilans2. 1. From the Department of Cardiology, Cincinnati Children's Hospital Medical Center, The Heart Institute, OH (K.G., R.J.C., D.S.S., J.B.A., T.K.K.); and Department of Cardiology, The Heart Center, Lucile Packard Children's Hospital, Palo Alto, CA (D.K.). Karine.Guerrier@cchmc.org. 2. From the Department of Cardiology, Cincinnati Children's Hospital Medical Center, The Heart Institute, OH (K.G., R.J.C., D.S.S., J.B.A., T.K.K.); and Department of Cardiology, The Heart Center, Lucile Packard Children's Hospital, Palo Alto, CA (D.K.).
Abstract
BACKGROUND: Risk associated with short QT interval has recently received recognition. European studies suggest a prevalence of 0.02% to 0.1% in the adult population, but similar studies in pediatric patients are limited. We sought to determine the prevalence of short QT interval in a pediatric population and associated clinical characteristics and outcomes. METHODS AND RESULTS: Retrospective review of an ECG database at a single pediatric institution. The database was queried for ECGs on patients ≤21 years with electronically measured QTc of 140 to 340 ms. Patients with QTc of 140 to 340 ms confirmed by a pediatric electrophysiologist were identified for chart review for associated clinical characteristics, symptoms, and outcome. Patients with and without symptoms were compared in an attempt to identify variables associated with outcome. The query included 272 504 ECGs on 99 380 unique patients. Forty-five patients (35 men, 76%) had QTc ≤340 ms, for a prevalence of 0.05%. Median age was 15 years (interquartile range, 2-17), median QT 330 ms (interquartile range, 280-360), and median QTc 323 ms (IQR, 313-332). Women had significantly shorter QTc compared with men (312 versus 323 ms; P=0.03). Two deaths were noted in chart review--one from respiratory failure and the second of unknown pathogenesis in a patient with dilated cardiomyopathy. CONCLUSIONS: Short QT interval was a rare finding in this pediatric population, with a prevalence of 0.05%. Male predominance was identified, although the median QT interval was significantly shorter in women. There seem to be no unifying clinical characteristics for this pediatric patient cohort with short QT interval.
BACKGROUND: Risk associated with short QT interval has recently received recognition. European studies suggest a prevalence of 0.02% to 0.1% in the adult population, but similar studies in pediatric patients are limited. We sought to determine the prevalence of short QT interval in a pediatric population and associated clinical characteristics and outcomes. METHODS AND RESULTS: Retrospective review of an ECG database at a single pediatric institution. The database was queried for ECGs on patients ≤21 years with electronically measured QTc of 140 to 340 ms. Patients with QTc of 140 to 340 ms confirmed by a pediatric electrophysiologist were identified for chart review for associated clinical characteristics, symptoms, and outcome. Patients with and without symptoms were compared in an attempt to identify variables associated with outcome. The query included 272 504 ECGs on 99 380 unique patients. Forty-five patients (35 men, 76%) had QTc ≤340 ms, for a prevalence of 0.05%. Median age was 15 years (interquartile range, 2-17), median QT 330 ms (interquartile range, 280-360), and median QTc 323 ms (IQR, 313-332). Women had significantly shorter QTc compared with men (312 versus 323 ms; P=0.03). Two deaths were noted in chart review--one from respiratory failure and the second of unknown pathogenesis in a patient with dilated cardiomyopathy. CONCLUSIONS: Short QT interval was a rare finding in this pediatric population, with a prevalence of 0.05%. Male predominance was identified, although the median QT interval was significantly shorter in women. There seem to be no unifying clinical characteristics for this pediatric patient cohort with short QT interval.
Authors: Roberta Pereira; Oscar Campuzano; Georgia Sarquella-Brugada; Sergi Cesar; Anna Iglesias; Josep Brugada; Fernando E S Cruz Filho; Ramon Brugada Journal: Clin Res Cardiol Date: 2017-03-16 Impact factor: 5.460
Authors: Travis S Heath; Rachel G Greenberg; Susan R Hupp; David A Turner; Christoph P Hornik; Kanecia O Zimmerman Journal: J Pediatr Pharmacol Ther Date: 2018 Mar-Apr
Authors: Peter J Schwartz; Michael J Ackerman; Charles Antzelevitch; Connie R Bezzina; Martin Borggrefe; Bettina F Cuneo; Arthur A M Wilde Journal: Nat Rev Dis Primers Date: 2020-07-16 Impact factor: 52.329
Authors: Oscar Campuzano; Georgia Sarquella-Brugada; Sergi Cesar; Elena Arbelo; Josep Brugada; Ramon Brugada Journal: Front Cardiovasc Med Date: 2018-10-29
Authors: Ibrahim El-Battrawy; Johanna Besler; Volker Liebe; Rainer Schimpf; Erol Tülümen; Boris Rudic; Siegfried Lang; Christian Wolpert; Xiaobo Zhou; Ibrahim Akin; Martin Borggrefe Journal: J Am Heart Assoc Date: 2018-12-04 Impact factor: 5.501
Authors: Iris D Noordman; Anthonie L Duijnhouwer; Misty Coert; Melanie Bos; Marlies Kempers; Henri J L M Timmers; Zina Fejzic; Janiëlle A E M van der Velden; Livia Kapusta Journal: J Clin Endocrinol Metab Date: 2020-11-01 Impact factor: 5.958